Number needed to treat matters, or why statins AREN’T in the water supply: The SPIRE trials and bococizumab

Saying that PCSK9 inhibitors are a hot topic in medicine right now is a lot like saying that Donald Trump is a controversial president, or that you shouldn’t reference politics on a blog meant to have broad appeal across the political spectrum. I mean, it’s obvious, right? But as both a primary care doctor and […]